Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. - Wikidata - wikimedia - TriplyDB

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

http://www.wikidata.org/entity/Q30354426

about

Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine.Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations.Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis.Genetically attenuated malaria parasites as vaccines.CD8+ T-cell mediated anti-malaria protection induced by malaria vaccines; assessment of hepatic CD8+ T cells by SCBC assay.DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men.Controlled Human Malaria Infection: Applications, Advances and Challenges.Evaluating anti-disease immunity to malaria and implications for vaccine design.A Review of Biotechnological Artemisinin Production in Plants.Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice.Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.Novel ELISA method as exploratory tool to assess immunity induced by radiated attenuated sporozoites to decipher protective immunity.Zika Vaccines: Role for Controlled Human Infection.Protection from experimental cerebral malaria with a single intravenous or subcutaneous whole-parasite immunization.Immunization of malaria pre-exposed volunteers with PfSPZ Vaccine elicits long-lived IgM invasion-inhibitory and complement-fixing antibodies.Infectious Sporozoites of Plasmodium berghei Effectively Activate Liver CD8α+ Dendritic Cells.Whole blood transcriptome changes following controlled human malaria infection in malaria pre-exposed volunteers correlate with parasite prepatent period.Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Sporozoite Vaccine in Tanzanian Adults Malaria Vaccines: Recent Advances and New Horizons Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development A sporozoite-based vaccination platform against human malaria

P2860

Q30234589-6F8978E0-2FAC-4DED-8B8E-5544F2EBF728 Q38685505-2FF990A9-C8C7-4C1A-8EBB-EC993D56F7C0 Q38747458-F095987B-A9DA-49EF-A78C-C261FD53A020 Q38949224-D2B252A7-7850-4806-B52D-2234CAA74638 Q40042826-2A5D1557-1CB1-44AB-B75D-FA726C077176 Q40096524-5586CF83-91B1-45ED-8D4C-92FEE55745AF Q40173318-89C429CA-6F93-46FD-AB8B-661BE56B0C39 Q40270575-A5818AC1-3C1B-4C54-AEA3-31B286AD93CE Q41927762-6B0E0801-BDE0-4A9C-975A-22CBC819F628 Q43923962-4822258F-DA6F-4DA4-84D1-86B40EEF53EB Q44168331-C791E853-F020-42F5-988D-676B95D136CF Q46222698-A06B6B09-E16D-454E-9A3C-D11E2849146C Q46253594-D2BEAC39-8FE5-46C0-824D-8A31EF828F56 Q47099112-A7BE7AA6-E93E-45B0-8C07-59FD4A57F0DC Q47106697-5EF1D4D2-2A4B-4738-A00F-16B4D7EEB69E Q47135372-159C1EA3-8D76-47A6-A621-DF9924F1D502 Q47266530-70FCE29E-FA79-40FE-8436-43EA6B724719 Q49958400-B4E5165A-921D-493D-99F9-F0B5B695208A Q50041449-CB2DEE3F-66F4-455B-AAC6-A347E06B8A0F Q50199352-A50FF838-F038-4E0A-9AC0-301EFC1132E4 Q55381231-FD243BF6-A159-4D63-82CE-986A28CFF825 Q56349366-2C84AE03-CB78-4750-B66E-F52C09FDFCFB Q56362064-43A66882-B06B-49A0-ACDE-31CD714E54C8 Q56514706-0D42A4C7-4AC1-441B-BF91-25F197849B1C Q58707703-69318269-89FF-43E9-94D5-E4355FB3923B

P2860

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

http://www.wikidata.org/entity/Q30354426

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

@ast

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

@en

type

label

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

@ast

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

@en

prefLabel

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

@ast

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

@en

P1433

Q30354426-207495F9-0B1D-4371-BA80-329691BCC3B8

P1476

Q30354426-C98DED3C-9444-414E-AE36-382C6CE5B29C

P2093

Q30354426-05A48DFB-9B79-42AD-B726-6DB05026D655

Q30354426-100F4BA9-BD97-4F36-9860-F212A9E41632

Q30354426-14673A88-A499-4259-8F50-21C746EDCDCB

Q30354426-14DC15A9-547F-453D-9ED1-ABC4453756AF

Q30354426-17E62EED-2503-4C1E-97B3-040ABAFC6FA3

Q30354426-23E70916-7BB1-4EA4-9B47-69B9DAB90679

Q30354426-27EE9E73-1930-4A68-BB8A-3B37EBDEB293

Q30354426-2D583AE2-A180-4C28-99D9-92BF11B7107D

Q30354426-30318750-B22D-499A-B01E-4A8E47D64D25

Q30354426-3A38F041-989D-4FD0-8319-1551E072EE45

P2860

Q30354426-029D33F6-5A67-4F02-A904-C13E6DFB573D

Q30354426-04BE4DB2-A346-43C7-8882-9B7505B3C876

Q30354426-06E52B1B-84BB-4286-9C35-95FDAD425ECA

Q30354426-0C2A3113-B093-4CC2-8045-2D3F1F8BDDFD

Q30354426-0C615B15-DC9D-4D38-A1FB-150EAC9A8993

Q30354426-0FF62C70-4DBA-4925-B96C-2EB0FF902076

Q30354426-12B43564-4D05-47E9-94FA-BB4747D5D7C9

Q30354426-2FACF28D-EC2A-4C81-B7DB-4FA65D4C348D

Q30354426-377F3946-5B50-4629-A6AD-21BCAA60AB11

Q30354426-3D2CCB2C-81CA-47D5-A4CF-15AE1E27A632

P304

Q30354426-7ED0A459-406D-417D-88A8-5F71A62B4285

P31

Q30354426-2F2ECA16-4A86-41BA-A804-D11A2CFDD722

P356

Q30354426-94510949-C5BD-4416-9E08-133894DED9B6

P433

Q30354426-EF6CC027-0917-4919-949A-D1DC6C267CD0

P478

Q30354426-8E597D41-8ACF-4342-AE30-5E346FE12342

P50

Q30354426-5F86329A-F152-49DA-9E43-722ED30F5B39

Q30354426-C127BEC9-837D-488F-8B31-7E53ADC7D70E

Q30354426-FA27DFB7-9398-49C7-85C9-7060325141CB

P577

Q30354426-AB0036F8-F4FF-4970-81CA-D1F7EE7FE525

P698

Q30354426-976B53EA-DC38-4DF3-9B83-A56427A1EDAE

P921

Q30354426-0C7D4392-6C7C-44B6-986D-B8F106FB61E2

Q30354426-DA016C81-7AD8-457E-B592-43C583109633

P932

Q30354426-93336914-60CE-4110-B8BE-14B6691F4878

P356

JCI.INSIGHT.89154

P1433

P1476

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

@en

P2093

Abraham G Eappen

http://www.w3.org/2001/XMLSchema#string

Adam J Ruben

http://www.w3.org/2001/XMLSchema#string

Alexandra Singer

http://www.w3.org/2001/XMLSchema#string

Amy Tillman

http://www.w3.org/2001/XMLSchema#string

Anita Manoj

http://www.w3.org/2001/XMLSchema#string

Anusha Gunasekera

http://www.w3.org/2001/XMLSchema#string

April Stafford

http://www.w3.org/2001/XMLSchema#string

Arnel Belmonte

http://www.w3.org/2001/XMLSchema#string

B Kim Lee Sim

http://www.w3.org/2001/XMLSchema#string

Bradley Hickey

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

Sample-ready multiplex qPCR assay for detection of malaria.

Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort

Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.

Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine.

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.

Multiplex qPCR for detection and absolute quantification of malaria

P304

e89154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI.INSIGHT.89154

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Mary Carrington

Stephen L Hoffman

P577

2017-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28097230

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

5214067

http://www.w3.org/2001/XMLSchema#string